Optimizing Antiplatelet Therapy in Cardiogenic Shock

Content

Case Presentation, Ravi J. Shah, M.D.
Anti-platelet Concerns and Pharmacodynamics in Cardiogenic Shock, George D. Dangas, M.D., Ph.D., MSCAI
Cangrelor: Trial Data, Indications, and Contraindications, Ehtisham Mahmud, M.D., FSCAI
Multivessel Intervention and Antiplatelet Therapy in Cardiogenic Shock, Alejandro Lemor, M.D.
Case Presentation with Questions, Ravi J. Shah, M.D.

Faculty

	George D. Dangas, MD, PhD, MSCAI		Alejandro Lemor, MD
	Ehtisham Mahmud, MD, FSCAI		Ravi J. Shah, MD
	Nadia Sutton, MD, MPH, FSCAI		Srihari Naidu, MD, FSCAI

Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Chiesi. No in-kind commercial support was received.

CME Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered